HUMAN PAPILLOMAVIRUS-RELATED MALIGNANT NEOPLASM
Clinical trials for HUMAN PAPILLOMAVIRUS-RELATED MALIGNANT NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new HUMAN PAPILLOMAVIRUS-RELATED MALIGNANT NEOPLASM trials appear
Sign up with your email to follow new studies for HUMAN PAPILLOMAVIRUS-RELATED MALIGNANT NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can reminders and education prevent cervical cancer? a new trial aims to find out.
Prevention OngoingThis trial tests whether a program that combines educational materials with electronic health record reminders can increase HPV vaccination rates among children and young adults aged 11–26 in four Appalachian states. The goal is to improve vaccine uptake and ultimately prevent ce…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED MALIGNANT NEOPLASM
Phase: NA • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
Could one HPV shot be enough? 20-Year study seeks answers
Knowledge-focused OngoingThis study is checking how long the HPV vaccine protects women who received one, two, or three doses. Researchers are following about 946 women from an earlier trial in Costa Rica for up to 20 years after their shots. By testing blood samples, they hope to learn if one dose might…
Matched conditions: HUMAN PAPILLOMAVIRUS-RELATED MALIGNANT NEOPLASM
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:34 UTC